A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure how much of the study drugs (clopidogrel and
LY2216684) reach the blood stream and how long it takes the body to dispose of them and to
determine how clopidogrel and LY2216684 might affect each other in the body. Information
about any side effects that may occur will also be collected.